ReviewFrontiers in public health2026
Food packaging-derived endocrine disruptors and breast cancer nutrition: dietary exposure, estrogen signaling, and survivorship implications.
Review in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Food packaging and other food contact materials are increasingly recognized as sources of dietary chemical exposure. Among the compounds that may migrate from packaging into foods, several classes are relevant to breast cancer nutrition because they can act as endocrine-disrupting chemicals, including bisphenols, phthalates, per- and polyfluoroalkyl substances, and selected non-intentionally added substances generated during food-contact material manufacture or use. These exposures do not replace established nutritional determinants of breast cancer outcomes, such as dietary quality, body weight, physical activity, and metabolic health. Rather, they represent an overlooked dimension of the food environment that may intersect with estrogen signaling, adipose inflammation, oxidative stress, epigenetic regulation, and treatment-related survivorship needs. Evidence linking packaging-derived endocrine disruptors to breast cancer remains heterogeneous and is strongest for mechanistic plausibility and exposure biology, while epidemiologic associations vary across compounds, timing of exposure, biomarkers, and tumor subtypes. This Mini Review synthesizes current evidence on food packaging-derived endocrine disruptors in relation to breast cancer nutrition, with emphasis on dietary exposure pathways, estrogen-related mechanisms, and practical survivorship implications. We propose that nutrition guidance for breast cancer survivors should include low-burden strategies to reduce avoidable food-contact chemical exposure, without promoting restrictive or anxiety-inducing dietary behavior. Future research should integrate dietary assessment, packaging-use patterns, biomonitoring, endocrine-metabolic biomarkers, and breast cancer outcomes to clarify modifiable exposure windows and prevention opportunities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.